Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
eniluracil
Also known as: ADH300004 (formerly 776C85)
print preview
bookmark
share with colleague
General Information
Company
Adherex Technologies Inc.
Description
Dihydropyrimidine dehydrogenase inhibitor
Molecular Target
Dihydropyrimidine dehydrogenase
Mechanism of Action
Dihydropryimidine dehydrogenase inhibitor
Latest Stage of Development
Phase II
Indication
Breast cancer
Partner
GlaxoSmithKline plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy